We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gyg Plc | LSE:GYG | London | Ordinary Share | GB00BZ4FM652 | ORD GBP0.002 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 30.00 | 25.00 | 45.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:7820T Gyrus Group PLC 02 January 2004 2 January 2004 Gyrus Group PLC Confirmation of Board changes at Gyrus Group PLC Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices to reduce trauma and complications in surgery, today confirms that the changes to its Board of Directors that were announced in detail in September, 2003 have taken effect as follows: Simon Shaw has been appointed to the Board with effect from 1 January 2004. Also with effect from 1 January, Tom Murphy resigns as Finance Director to return to the US to take up his new appointment within the Group as President of Gyrus Medical Inc. Tom Murphy has served as group Finance Director since 2001 and during his tenure has played a key role in the development of Gyrus through the acquisition of a number of businesses and the day-to-day financial management of the Group. Simon Shaw, aged 38, joined Gyrus on 1 October, 2003 as Chief Financial Officer. He has financial and management experience gained both in the City and Industry. His last post was Chief Operating Officer of Profile Therapeutics plc a medical devices business, which he joined in 1997 and was responsible for its flotation in 2000. Prior to that he was a corporate financier with Hambros Bank Limited, and previously WestLB, where he advised on flotations, fund raisings and international mergers and acquisitions. He qualified as a Chartered Accountant with Arthur Andersen & Co. in 1990. Simon Shaw was a director of Profile Therapeutics plc, from July 1997 to April 2003. Gyrus can advise that there are no further details relating to the appointment of Simon Shaw which it is obliged to disclose under paragraph 6.F.2. (b-g) of the Listing Rules of the UK Listing Authority. Enquiries: Gyrus: Brian Steer, Executive Chairman Today 07768 686 190 Thereafter 01189 219 750 Simon Shaw, Chief Financial Officer Today 07739 807 625 Thereafter 01189 219 750 Financial Dynamics: Ben Atwell 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange END BOADGGGMGZNGDZM
1 Year Gyg Chart |
1 Month Gyg Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions